Van Plew Daniel P
Insider CIK 1411984 · REGN SVP & General Mgr Industrial O
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2025-12-09 | 2025-12-11 | 2,552 | $701.51 | $1.79M | 21,673 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2025-12-08 | 2025-12-09 | 1,906 | $712.94 | $1.36M | 24,225 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2025-12-05 | 2025-12-09 | 18,315 | — | $0 | 18,315 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2025-12-05 | 2025-12-09 | 3,715 | — | $0 | 26,131 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-12-16 | 2024-12-18 | 969 | $730.81 | $708.2K | 34,792 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-12-09 | 2024-12-10 | 492 | $787.00 | $387.2K | 35,761 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2024-12-06 | 2024-12-10 | 13,472 | — | $0 | 13,472 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2024-12-06 | 2024-12-10 | 3,499 | — | $0 | 36,253 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 620 | $944.30 | $585.5K | 21,550 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 2,691 | $943.51 | $2.54M | 22,170 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 200 | $951.77 | $190.4K | 20,378 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 4,261 | $940.44 | $4.01M | 25,136 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 750 | $939.60 | $704.7K | 29,397 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 226 | $938.13 | $212.0K | 30,147 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 439 | $937.94 | $411.8K | 30,373 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 95 | $945.81 | $89.9K | 21,455 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 240 | $947.81 | $227.5K | 21,215 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 150 | $948.70 | $142.3K | 21,065 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 112 | $949.07 | $106.3K | 20,953 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 375 | $950.45 | $356.4K | 20,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2024-02-14 | 2024-02-16 | 275 | $941.41 | $258.9K | 24,861 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-02-09 | 2024-02-13 | 23,125 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2024-02-09 | 2024-02-13 | 12,250 | — | $0 | 12,250 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-02-09 | 2024-02-13 | 8,600 | $951.68 | $8.18M | 24,028 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-02-09 | 2024-02-13 | 12,250 | $372.46 | $4.56M | 32,628 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2024-02-09 | 2024-02-13 | 16,341 | $951.68 | $15.55M | 30,812 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2024-02-09 | 2024-02-13 | 23,125 | $381.40 | $8.82M | 47,153 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-12-11 | 2023-12-12 | 2,552 | $844.09 | $2.15M | 21,047 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-12-11 | 2023-12-12 | 669 | $844.09 | $564.7K | 20,378 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 11,473 | — | $0 | 11,473 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-12-08 | 2023-12-12 | 1,108 | $843.79 | $934.9K | 20,400 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2023-12-08 | 2023-12-12 | 3,199 | — | $0 | 23,599 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-25 | 138 | $835.67 | $115.3K | 27,567 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-25 | 625 | $836.32 | $522.7K | 26,942 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-25 | 300 | $837.53 | $251.3K | 26,642 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-25 | 667 | $838.37 | $559.2K | 25,975 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-25 | 148 | $839.28 | $124.2K | 25,827 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-25 | 46 | $840.74 | $38.7K | 25,781 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-25 | 363 | $841.15 | $305.3K | 25,418 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-25 | 617 | $842.66 | $519.9K | 24,801 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-25 | 759 | $843.31 | $640.1K | 24,042 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2023-08-24 | 2023-08-25 | 2,534 | $844.27 | $2.14M | 21,508 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2023-08-23 | 2023-08-25 | 23,125 | — | $0 | 23,125 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2023-08-23 | 2023-08-25 | 16,928 | $842.66 | $14.26M | 27,705 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2023-08-23 | 2023-08-25 | 23,125 | $381.40 | $8.82M | 44,633 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2022-12-16 | 2022-12-20 | 14,019 | — | $0 | 14,019 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2022-12-16 | 2022-12-20 | 3,798 | — | $0 | 33,884 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2022-12-09 | 2022-12-13 | 492 | $753.28 | $370.6K | 30,086 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 629 | $747.28 | $470.0K | 30,579 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 1,164 | $746.42 | $868.8K | 31,208 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 256 | $745.56 | $190.9K | 32,372 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 780 | $744.56 | $580.8K | 32,628 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 101 | $743.66 | $75.1K | 33,408 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 99 | $742.58 | $73.5K | 33,509 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 1,002 | $741.34 | $742.8K | 33,608 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 1,808 | $740.29 | $1.34M | 34,610 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 3,124 | $739.48 | $2.31M | 36,418 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 944 | $738.57 | $697.2K | 39,542 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 373 | $737.37 | $275.0K | 40,486 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 1,005 | $736.46 | $740.1K | 40,859 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 686 | $735.57 | $504.6K | 41,864 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-23 | 2022-11-25 | 1 | $748.17 | $748 | 30,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-11-22 | 2022-11-25 | 50,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2022-11-22 | 2022-11-25 | 38,028 | $741.81 | $28.21M | 42,550 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-11-22 | 2022-11-25 | 50,000 | $378.98 | $18.95M | 80,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-07 | 2022-11-08 | 2,782 | $746.56 | $2.08M | 30,982 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-07 | 2022-11-08 | 1,468 | $745.51 | $1.09M | 33,764 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-07 | 2022-11-08 | 2,032 | $744.61 | $1.51M | 35,232 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-07 | 2022-11-08 | 100 | $742.79 | $74.3K | 38,364 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-07 | 2022-11-08 | 404 | $747.20 | $301.9K | 30,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-11-07 | 2022-11-08 | 1,100 | $743.39 | $817.7K | 37,264 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-11-04 | 2022-11-08 | 34,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2022-11-04 | 2022-11-08 | 26,114 | $725.84 | $18.95M | 38,464 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-11-04 | 2022-11-08 | 34,000 | $381.92 | $12.99M | 64,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 1,052 | $716.28 | $753.5K | 32,253 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 861 | $715.39 | $616.0K | 33,305 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 267 | $714.42 | $190.8K | 34,166 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 572 | $713.67 | $408.2K | 34,433 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 110 | $712.44 | $78.4K | 35,005 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 174 | $721.38 | $125.5K | 30,657 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 2 | $710.25 | $1.4K | 35,185 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 87 | $709.93 | $61.8K | 35,187 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 647 | $717.59 | $464.3K | 31,606 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 435 | $718.50 | $312.5K | 31,171 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 159 | $719.72 | $114.4K | 31,012 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 181 | $720.41 | $130.4K | 30,831 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 70 | $711.85 | $49.8K | 35,115 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-09-12 | 2022-09-13 | 79 | $722.83 | $57.1K | 30,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-09-09 | 2022-09-13 | 40,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2022-09-09 | 2022-09-13 | 35,304 | $730.96 | $25.81M | 35,274 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-09-09 | 2022-09-13 | 40,000 | $555.67 | $22.23M | 70,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 200 | $610.41 | $122.1K | 35,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 400 | $609.62 | $243.8K | 36,003 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 800 | $608.29 | $486.6K | 36,403 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 156 | $607.94 | $94.8K | 37,203 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 600 | $612.44 | $367.5K | 34,403 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 600 | $614.53 | $368.7K | 33,803 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 300 | $615.20 | $184.6K | 33,503 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 734 | $616.40 | $452.4K | 32,769 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 1,176 | $617.48 | $726.2K | 31,593 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 1,015 | $618.16 | $627.4K | 30,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2022-02-23 | 2022-02-24 | 800 | $611.65 | $489.3K | 35,003 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2022-02-22 | 2022-02-24 | 40,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2022-02-22 | 2022-02-24 | 33,219 | $610.56 | $20.28M | 37,359 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2022-02-22 | 2022-02-24 | 40,000 | $399.66 | $15.99M | 70,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-12-11 | 2021-12-14 | 697 | $664.34 | $463.0K | 30,578 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2021-12-08 | 2021-12-10 | 18,548 | — | $0 | 18,548 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2021-12-08 | 2021-12-10 | 4,344 | — | $0 | 31,275 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-11-16 | 2021-11-17 | 350 | $655.03 | $229.3K | 30,731 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-11-16 | 2021-11-17 | 200 | $657.18 | $131.4K | 30,531 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-11-16 | 2021-11-17 | 697 | $658.50 | $459.0K | 29,834 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-11-16 | 2021-11-17 | 2,403 | $659.42 | $1.58M | 27,431 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-11-16 | 2021-11-17 | 500 | $660.51 | $330.3K | 26,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-11-16 | 2021-11-17 | 1,260 | $654.33 | $824.5K | 31,081 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-11-16 | 2021-11-17 | 840 | $653.41 | $548.9K | 32,341 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-11-16 | 2021-11-17 | 528 | $652.20 | $344.4K | 33,181 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-11-15 | 2021-11-17 | 25,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-11-15 | 2021-11-17 | 18,222 | $641.50 | $11.69M | 33,709 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-11-15 | 2021-11-17 | 25,000 | $270.43 | $6.76M | 51,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 400 | $611.57 | $244.6K | 31,131 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 900 | $612.45 | $551.2K | 30,231 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 1,600 | $613.34 | $981.3K | 28,631 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 1,120 | $614.33 | $688.0K | 27,511 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 280 | $615.22 | $172.3K | 27,231 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 244 | $606.50 | $148.0K | 33,290 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 762 | $607.21 | $462.7K | 32,528 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 100 | $610.81 | $61.1K | 31,531 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 200 | $609.25 | $121.8K | 31,631 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 697 | $608.50 | $424.1K | 31,831 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2021-08-10 | 2021-08-10 | 300 | $616.27 | $184.9K | 26,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2021-08-09 | 2021-08-10 | 25,000 | — | $0 | 25,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2021-08-09 | 2021-08-10 | 25,000 | $270.43 | $6.76M | 51,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2021-08-09 | 2021-08-10 | 18,397 | $617.68 | $11.36M | 33,534 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2020-12-09 | 2020-12-11 | 19,950 | — | $0 | 19,950 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2020-12-09 | 2020-12-11 | 1,930 | — | $0 | 21,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2020-12-09 | 2020-12-11 | 5,000 | — | $0 | 26,931 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-08-25 | 2020-08-27 | 1,288 | $614.24 | $791.1K | 20,001 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-08-25 | 2020-08-27 | 7,981 | $610.41 | $4.87M | 28,873 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-08-25 | 2020-08-27 | 10,256 | $609.71 | $6.25M | 36,854 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-08-25 | 2020-08-27 | 1,980 | $611.40 | $1.21M | 26,893 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-08-25 | 2020-08-27 | 1,560 | $613.62 | $957.2K | 21,289 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-08-25 | 2020-08-27 | 4,044 | $612.49 | $2.48M | 22,849 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-08-20 | 2020-08-24 | 75,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-08-20 | 2020-08-24 | 47,891 | $614.09 | $29.41M | 47,110 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-08-20 | 2020-08-24 | 75,000 | $179.13 | $13.43M | 95,001 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 500 | $559.20 | $279.6K | 64,516 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 100 | $556.92 | $55.7K | 67,734 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 600 | $557.59 | $334.6K | 67,134 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 2,118 | $558.43 | $1.18M | 65,016 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 3,231 | $560.53 | $1.81M | 61,285 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 4,988 | $561.55 | $2.80M | 56,297 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 2,077 | $562.45 | $1.17M | 54,220 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 700 | $569.42 | $398.6K | 28,251 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 3,040 | $568.57 | $1.73M | 28,951 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 3,753 | $567.35 | $2.13M | 31,991 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 7,297 | $566.47 | $4.13M | 35,744 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 5,984 | $565.49 | $3.38M | 43,041 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 3,000 | $564.54 | $1.69M | 49,025 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-05-07 | 2020-05-08 | 2,195 | $563.58 | $1.24M | 52,025 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-05-06 | 2020-05-08 | 52,500 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-05-06 | 2020-05-08 | 33,079 | — | $0 | 52,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-05-06 | 2020-05-08 | 17,779 | $555.77 | $9.88M | 43,551 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-05-06 | 2020-05-08 | 52,500 | $52.03 | $2.73M | 96,051 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-05-06 | 2020-05-08 | 28,217 | $555.77 | $15.68M | 67,834 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-05-06 | 2020-05-08 | 33,079 | $52.03 | $1.72M | 61,330 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-26 | 2020-02-27 | 200 | $451.61 | $90.3K | 43,693 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-26 | 2020-02-27 | 300 | $452.53 | $135.8K | 43,393 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-26 | 2020-02-27 | 1,000 | $453.57 | $453.6K | 42,393 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-26 | 2020-02-27 | 711 | $454.53 | $323.2K | 41,682 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-26 | 2020-02-27 | 1,300 | $455.50 | $592.1K | 40,382 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-26 | 2020-02-27 | 1,435 | $456.50 | $655.1K | 38,947 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-26 | 2020-02-27 | 210 | $460.30 | $96.7K | 28,251 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-26 | 2020-02-27 | 1,425 | $459.33 | $654.5K | 28,461 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-26 | 2020-02-27 | 5,274 | $458.45 | $2.42M | 29,886 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | S Sale | 2020-02-26 | 2020-02-27 | 3,787 | $457.59 | $1.73M | 35,160 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise deriv | 2020-02-25 | 2020-02-27 | 32,735 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | M Exercise | 2020-02-25 | 2020-02-27 | 32,735 | $30.63 | $1.00M | 60,986 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | F Tax w/h | 2020-02-25 | 2020-02-27 | 17,093 | $447.30 | $7.65M | 43,893 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award deriv | 2019-12-11 | 2019-12-13 | 24,500 | — | $0 | 24,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2019-12-11 | 2019-12-13 | 2,625 | — | $0 | 23,251 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS, | A Award | 2019-12-11 | 2019-12-13 | 5,000 | — | $0 | 28,251 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2018-12-12 | 2018-12-14 | 46,250 | — | $0 | 46,250 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2017-12-12 | 2017-12-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2016-12-16 | 2016-12-19 | 34,000 | — | $0 | 34,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2016-05-18 | 2016-05-19 | 4,413 | $385.77 | $1.70M | 1,921 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2016-05-17 | 2016-05-19 | 9,460 | — | $0 | 32,735 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2016-05-17 | 2016-05-19 | 4,301 | $388.14 | $1.67M | 6,334 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2016-05-17 | 2016-05-19 | 746 | $388.14 | $289.6K | 10,635 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2016-05-17 | 2016-05-19 | 9,460 | $30.63 | $289.8K | 11,381 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-12-16 | 2015-12-18 | 1,921 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2015-12-16 | 2015-12-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-12-16 | 2015-12-18 | 1,921 | $52.03 | $99.9K | 1,921 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-11-10 | 2015-11-10 | 850 | $551.45 | $468.7K | 4,273 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-11-10 | 2015-11-10 | 50 | $552.50 | $27.6K | 4,223 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-11-10 | 2015-11-10 | 2,000 | $554.39 | $1.11M | 2,223 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-11-10 | 2015-11-10 | 1,000 | $556.00 | $556.0K | 1,223 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-11-10 | 2015-11-10 | 1,223 | $557.14 | $681.4K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-11-06 | 2015-11-10 | 5,486 | — | $0 | 42,195 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-11-06 | 2015-11-10 | 5,700 | — | $0 | 47,681 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-11-06 | 2015-11-10 | 300 | $559.49 | $167.8K | 7,797 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-11-06 | 2015-11-10 | 2,674 | $559.49 | $1.50M | 5,123 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-11-06 | 2015-11-10 | 5,700 | $30.63 | $174.6K | 5,700 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-11-06 | 2015-11-10 | 311 | $559.49 | $174.0K | 5,389 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-11-06 | 2015-11-10 | 5,486 | $30.63 | $168.0K | 8,097 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-11-06 | 2015-11-10 | 2,778 | $559.49 | $1.55M | 2,611 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-08-06 | 2015-08-07 | 1,000 | $582.12 | $582.1K | 3,028 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-08-06 | 2015-08-07 | 1,000 | $583.89 | $583.9K | 2,028 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-08-06 | 2015-08-07 | 1,128 | $586.24 | $661.3K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-08-06 | 2015-08-07 | 900 | $585.02 | $526.5K | 1,128 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-08-05 | 2015-08-07 | 4,605 | — | $0 | 53,381 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-08-05 | 2015-08-07 | 4,095 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-08-05 | 2015-08-07 | 4,605 | $30.63 | $141.1K | 4,605 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-08-05 | 2015-08-07 | 239 | $588.64 | $140.7K | 4,366 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-08-05 | 2015-08-07 | 2,251 | $588.64 | $1.33M | 2,115 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-08-05 | 2015-08-07 | 4,095 | $21.25 | $87.0K | 6,210 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-08-05 | 2015-08-07 | 147 | $588.64 | $86.5K | 6,063 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-08-05 | 2015-08-07 | 2,035 | $588.64 | $1.20M | 4,028 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-05-26 | 2015-05-26 | 3,886 | $508.53 | $1.98M | 7,605 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-05-26 | 2015-05-26 | 6,879 | $507.34 | $3.49M | 11,491 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-05-26 | 2015-05-26 | 7,506 | $509.34 | $3.82M | 99 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-05-26 | 2015-05-26 | 99 | $510.02 | $50.5K | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-05-22 | 2015-05-26 | 26,250 | — | $0 | 57,986 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-05-22 | 2015-05-26 | 13,800 | — | $0 | 4,095 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-05-22 | 2015-05-26 | 6,823 | $516.48 | $3.52M | 18,370 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-05-22 | 2015-05-26 | 13,800 | $21.25 | $293.3K | 25,760 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-05-22 | 2015-05-26 | 12,734 | $516.48 | $6.58M | 11,960 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-05-22 | 2015-05-26 | 1,556 | $516.48 | $803.6K | 24,694 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-05-22 | 2015-05-26 | 26,250 | $30.63 | $804.0K | 26,250 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-05-22 | 2015-05-26 | 567 | $516.48 | $292.8K | 25,193 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-02-23 | 2015-02-24 | 1,700 | $427.12 | $726.1K | 24,136 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-02-23 | 2015-02-24 | 2,100 | $428.27 | $899.4K | 22,036 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-02-23 | 2015-02-24 | 3,331 | $429.09 | $1.43M | 18,705 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2015-02-23 | 2015-02-24 | 2,300 | $426.08 | $980.0K | 25,836 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2015-02-20 | 2015-02-24 | 20,000 | — | $0 | 17,895 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2015-02-20 | 2015-02-24 | 20,000 | $21.25 | $425.0K | 38,705 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-02-20 | 2015-02-24 | 1,000 | $424.70 | $424.7K | 37,705 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2015-02-20 | 2015-02-24 | 9,569 | $424.70 | $4.06M | 28,136 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2014-12-18 | 2014-12-19 | 3,264 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2014-12-18 | 2014-12-19 | 3,264 | $30.63 | $100.0K | 18,705 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-12-16 | 2014-12-18 | 52,500 | — | $0 | 85,579 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2014-12-16 | 2014-12-18 | 40,000 | — | $0 | 40,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-11-13 | 2014-11-14 | 1,501 | $399.95 | $600.3K | 15,441 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-11-13 | 2014-11-14 | 7,074 | $399.21 | $2.82M | 16,942 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2014-11-12 | 2014-11-14 | 18,700 | — | $0 | 37,895 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2014-11-12 | 2014-11-14 | 18,700 | $21.25 | $397.4K | 34,141 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-11-12 | 2014-11-14 | 996 | $398.93 | $397.3K | 33,145 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-11-12 | 2014-11-14 | 9,129 | $398.93 | $3.64M | 24,016 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-08-07 | 2014-08-07 | 6,806 | $338.37 | $2.30M | 15,441 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2014-08-06 | 2014-08-07 | 15,000 | — | $0 | 56,595 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-08-06 | 2014-08-07 | 7,246 | $336.11 | $2.44M | 22,247 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-08-06 | 2014-08-07 | 948 | $336.11 | $318.6K | 29,493 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2014-08-06 | 2014-08-07 | 15,000 | $21.25 | $318.8K | 30,441 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-05-23 | 2014-05-23 | 3,000 | $295.33 | $886.0K | 17,810 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2014-05-23 | 2014-05-23 | 2,369 | $296.70 | $702.9K | 15,441 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2014-05-22 | 2014-05-23 | 11,200 | — | $0 | 71,595 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-05-22 | 2014-05-23 | 803 | $296.19 | $237.8K | 25,838 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2014-05-22 | 2014-05-23 | 5,028 | $296.19 | $1.49M | 20,810 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2014-05-22 | 2014-05-23 | 11,200 | $21.25 | $238.0K | 26,641 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-12-18 | 2013-12-19 | 4,705 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-12-18 | 2013-12-19 | 4,705 | $21.25 | $100.0K | 15,441 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2013-12-13 | 2013-12-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2013-12-13 | 2013-12-17 | 52,500 | — | $0 | 84,236 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-19 | 600 | $303.01 | $181.8K | 23,536 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-19 | 1,444 | $304.16 | $439.2K | 22,092 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-19 | 3,556 | $305.14 | $1.09M | 18,536 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-19 | 3,600 | $306.40 | $1.10M | 14,936 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-19 | 3,200 | $307.28 | $983.3K | 11,736 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-19 | 1,000 | $308.26 | $308.3K | 10,736 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-19 | 1,400 | $301.42 | $422.0K | 24,136 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-19 | 2,600 | $300.62 | $781.6K | 25,536 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-19 | 2,800 | $299.34 | $838.2K | 28,136 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-09-18 | 2013-09-19 | 3,777 | $298.28 | $1.13M | 30,936 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-09-17 | 2013-09-19 | 52,500 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2013-09-17 | 2013-09-19 | 25,531 | $294.75 | $7.53M | 34,713 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-09-17 | 2013-09-19 | 52,500 | $16.80 | $882.0K | 63,236 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2013-09-17 | 2013-09-19 | 2,992 | $294.75 | $881.9K | 60,244 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-07 | 2013-05-08 | 2,037 | $262.15 | $534.0K | 10,736 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-07 | 2013-05-08 | 10,988 | $261.56 | $2.87M | 12,773 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2013-05-07 | 2013-05-08 | 700 | $260.88 | $182.6K | 23,761 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-05-06 | 2013-05-08 | 29,048 | — | $0 | 52,500 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2013-05-06 | 2013-05-08 | 3,902 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2013-05-06 | 2013-05-08 | 13,450 | $260.44 | $3.50M | 24,461 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2013-05-06 | 2013-05-08 | 1,873 | $260.44 | $487.8K | 37,911 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-05-06 | 2013-05-08 | 29,048 | $16.80 | $488.0K | 39,784 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2013-05-06 | 2013-05-08 | 3,902 | $16.80 | $65.6K | 10,736 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-12-20 | 2012-12-21 | 2,050 | — | $0 | 3,902 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-12-20 | 2012-12-21 | 2,050 | $16.80 | $34.4K | 6,834 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-12-14 | 2012-12-18 | 75,000 | — | $0 | 75,000 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | A Award deriv | 2012-12-14 | 2012-12-18 | 52,500 | — | $0 | 82,795 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-16 | 2012-11-16 | 657 | $153.48 | $100.8K | 22,868 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-16 | 2012-11-16 | 6,900 | $155.18 | $1.07M | 11,568 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-16 | 2012-11-16 | 2,000 | $156.17 | $312.3K | 9,568 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-16 | 2012-11-16 | 400 | $156.94 | $62.8K | 9,168 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-16 | 2012-11-16 | 4,384 | $157.44 | $690.2K | 4,784 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-11-16 | 2012-11-16 | 4,400 | $154.77 | $681.0K | 18,468 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise deriv | 2012-10-25 | 2012-10-26 | 30,000 | — | $0 | 0 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2012-10-25 | 2012-10-26 | 4,121 | $159.55 | $657.5K | 35,447 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | M Exercise | 2012-10-25 | 2012-10-26 | 30,000 | $21.92 | $657.6K | 39,568 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | F Tax w/h | 2012-10-25 | 2012-10-26 | 11,922 | $159.55 | $1.90M | 23,525 | SEC↗ |
| REGN REGENERON PHARMACEUTICALS | S Sale | 2012-04-30 | 2012-04-30 | 13,143 | $136.42 | $1.79M | 9,568 | SEC↗ |